Ginsenoside F2
Product Specifications
CAS Number
62025-49-4
Target
Endogenous Metabolite|||Apoptosis|||Autophagy
Related Pathways
Apoptosis|||Metabolism|||Autophagy
Purity
0.993
Bioactivity
Ginsenoside F2 has antiproliferative activity against breast cancer stem cells (CSCs) . It induces apoptosis in breast CSCs by activating the intrinsic apoptotic pathway and mitochondrial dysfunction.
Smiles
[H][C@@]1(CC[C@]2(C)[C@]1([H])[C@H](O)C[C@]1([H])[C@@]3(C)CC[C@H](O[C@]4([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C(C)(C)[C@]3([H])CC[C@@]21C)[C@](C)(CCC=C(C)C)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O
Molecular Formula
C42H72O13
Molecular Weight
785.01
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
362812 200 µL
DCLK1 (Doublecortin Like Kinase 1, DCDC3A, DCLK, DCAMKL1, Doublecortin And CaM Kinase-Like 1, Doublecortin domain-containing protein 3A, Doublecortin-like and CAM kinase-like 1)
Ask
View Details 
